ACC 2026: Post-TAVR treatments show potential in reducing cardiovascular risks

At ACC 2026, retrospective results were presented demonstrating the possibility of using pharmacotherapies for patients after ...
Medscape

TAVR vs Surgery in Low-Risk Patients: 7-Year Outcomes Show Equivalent Results

SAN FRANCISCO — After 7 years, transcatheter aortic valve replacement (TAVR) remains equivalent to surgery with respect to durability and safety in low-risk patients, a finding that may blunt ...
Medical Xpress

Study establishes new risk model for surgery after transcatheter aortic valve replacement

At the 2026 Society of Thoracic Surgeons (STS) Annual Meeting, investigators presented a late-breaking study focused on surgical aortic valve replacement (SAVR) following prior transcatheter aortic ...
Medscape

TAVR Comparable to Surgery at 6 Years in Low-Risk Patients, but Reinterventions Increase

At 6 years, transcatheter aortic valve replacement (TAVR) appears to rival surgery for major adverse events in low-risk patients with severe aortic stenosis, but it may come at the cost of more ...
EurekAlert!

Late-breaking study establishes new risk model for surgery after TAVR

NEW ORLEANS — January 29, 2026 — At the 2026 Society of Thoracic Surgeons (STS) Annual Meeting, investigators will present a late-breaking study focused on surgical aortic valve replacement (SAVR) ...
Kaleido Scope

Still and Cardiothoracic Surgery faculty publish findings on outcomes for high-risk patients following TAVR explantations

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...
Healio

TAVR remains noninferior to surgery for low-risk patients at 5 years

Please provide your email address to receive an email when new articles are posted on . At 5 years, there was no difference in death or disabling stroke between transcatheter aortic valve replacement ...
Healio

TAVR noninferior to surgery in real-world lower-risk patient population

Please provide your email address to receive an email when new articles are posted on . Transcatheter aortic valve replacement was noninferior to surgery for death and stroke at 1 year in a real-world ...
MedPage Today

Low-Risk TAVR Converging or Diverging With Surgical Outcomes, Depending on the Valve

SAN FRANCISCO -- A handful of years later, transcatheter aortic valve replacement (TAVR) still compared well against surgery in the PARTNER 3 and Evolut Low Risk trials. PARTNER 3 appeared to show a ...
Becker's Hospital Review

TAVR Has Lower Mortality Than Traditional Surgery

High-risk surgical patients with severe aortic stenosis who underwent a transcatheter aortic valve replacement experienced higher one-year survival rates than patients who underwent traditional ...

Older, high-risk patients can safely defer percutaneous coronary intervention until after aortic valve replacement

Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable ...
MedPage Today

First 7-Year Report of Low-Risk TAVR Reassures, With Finish Line Now in Sight

SAN FRANCISCO -- Long-term outcomes after transcatheter aortic valve replacement (TAVR) were looking more and more like those after surgical aortic valve replacement (SAVR) in low-risk patients, ...